Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic

CLINICAL RELEVANCE: Ocular pyogenic granulomas are benign vascular lesions that can be highly responsive to topical therapy in community optometry settings, helping to reduce unnecessary burden on tertiary eye care services. BACKGROUND: While their rapid onset and vascular appearance can be clinically alarming, the management of pyogenic granuloma primarily involves topical pharmaceuticals well suited to community-based care. This study analyses a 15-year cohort to establish the efficacy of topical management and define clear criteria for surgical referral. METHODS: A retrospective audit was performed on 49 cases of ocular pyogenic granuloma presenting to a hospital-based acute eye clinic between 2009 and 2024. Analysis focused on patient demographics, inciting triggers, resolution rates of various topical treatments, in addition to the clinical characteristics of cases requiring surgical intervention. RESULTS: = 0.044). Ruptured chalazia were the primary trigger (67.3%). Topical medications achieved complete resolution in 83.7% of cases. Fluorometholone demonstrated a 95.5% success rate, whereas Maxitrol achieved resolution in 71.4% of cases. Only 16.3% (7/43) of those treated with topical medications required surgical intervention. The median time to resolution was 1.0 month (IQR 1.0-2.0). Of all the 49 cases, a total of 11 (22.4%) were managed with surgical excision. Recalcitrant lesions (22.4%) were successfully managed with surgical excision without further recurrence. CONCLUSION: Most ocular pyogenic granulomas can be safely managed in primary care. Given their expertise in slit-lamp differential diagnosis and intraocular pressure monitoring, community optometrists are ideally positioned to initiate first-line topical steroid therapy, reserving surgical referral for recalcitrant lesions. Establishing this primary-care-first pathway ensures efficient patient care and prioritises tertiary resources for complex surgical cases.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Optometry
Published
2026-10-28
DOI
https://doi.org/10.1080/08164622.2026.2751180
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic

Philip Turnbull, Richard Johnson, Megan Yi-Han Wang
Clinical and Experimental Optometry
Ocular Oncology and Treatments
article

Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic

Philip Turnbull, Richard Johnson, Megan Yi-Han Wang
article en

Abstract

CLINICAL RELEVANCE: Ocular pyogenic granulomas are benign vascular lesions that can be highly responsive to topical therapy in community optometry settings, helping to reduce unnecessary burden on tertiary eye care services. BACKGROUND: While their rapid onset and vascular appearance can be clinically alarming, the management of pyogenic granuloma primarily involves topical pharmaceuticals well suited to community-based care. This study analyses a 15-year cohort to establish the efficacy of topical management and define clear criteria for surgical referral. METHODS: A retrospective audit was performed on 49 cases of ocular pyogenic granuloma presenting to a hospital-based acute eye clinic between 2009 and 2024. Analysis focused on patient demographics, inciting triggers, resolution rates of various topical treatments, in addition to the clinical characteristics of cases requiring surgical intervention. RESULTS: = 0.044). Ruptured chalazia were the primary trigger (67.3%). Topical medications achieved complete resolution in 83.7% of cases. Fluorometholone demonstrated a 95.5% success rate, whereas Maxitrol achieved resolution in 71.4% of cases. Only 16.3% (7/43) of those treated with topical medications required surgical intervention. The median time to resolution was 1.0 month (IQR 1.0-2.0). Of all the 49 cases, a total of 11 (22.4%) were managed with surgical excision. Recalcitrant lesions (22.4%) were successfully managed with surgical excision without further recurrence. CONCLUSION: Most ocular pyogenic granulomas can be safely managed in primary care. Given their expertise in slit-lamp differential diagnosis and intraocular pressure monitoring, community optometrists are ideally positioned to initiate first-line topical steroid therapy, reserving surgical referral for recalcitrant lesions. Establishing this primary-care-first pathway ensures efficient patient care and prioritises tertiary resources for complex surgical cases.

Clinical and Experimental Optometry
University of Auckland (NZ), Greenlane Clinical Centre (NZ)
Good health and well-being
Openalex Percentile: Top 9%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon